Nope.
The FDA has just said they can resubmit. Whether MSB wants to be thorough and fulfil the requested requirements is up to them.
Ann: FDA Notifies Clinical Data Sufficient for Refiling aGVHD BLA, page-71
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.44 |
Change
-0.008(0.52%) |
Mkt cap ! $1.678B | |||
| Open | High | Low | Value | Volume |
| $1.50 | $1.50 | $1.44 | $2.510M | 1.710M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 8 | 95201 | $1.44 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.45 | 34374 | 5 |
View Market Depth
| Last trade - 13.05pm 14/10/2024 (20 minute delay) ? |
| MSB (ASX) Chart |